Dublin, May 15, 2025 (GLOBE NEWSWIRE) -- The "Digifab Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" report has been added to ResearchAndMarkets.com's offering. This ...

Protherics of the UK says that it has put forward a New Drug Submission to the Health Products and Food Branch of Health Canada for DigiFab, its digoxin toxicity drug. Protherics of the UK says that ...

Paladin Labs Inc. has announced the Canadian launch of DigiFab™ Digoxin Immune Fab (Ovine). DigiFab™ is indicated for the treatment of patients with life-threatening or potentially life-threatening ...

BTG plc , the specialty pharmaceuticals company, announces that it has signed an agreement with Nycomed US Inc. concerning the accelerated transition to BTG on October 1, 2010 of marketing rights to ...

BTG plc, the global healthcare company, announced the start of a randomized double-blinded clinical study, initiated by researchers at the University of Maryland School of Medicine (UMSOM), that ...

Melville, NY - Savage Laboratories has announced the introduction of DigiFab? (digoxin immune fab [Ovine]), a digoxin toxicity antidote, to the US marketplace. The drug has been determined by the FDA ...

LONDON - Protherics plc bought out the rights to the dioxin-poisoning treatment Digitalis Antidot, or Digidot, from F. Hoffmann-La Roche Ltd., as a route to building an exclusive European franchise ...

(MENAFN- GlobeNewsWire - Nasdaq) The Key player in the digifab market is SERB Pharmaceuticals. North America was the largest region in the digifab market in 2024. The digifab market consists of sales ...